Tryp Therapeutics Inc.

Not featured in screeners

Not featured in screeners

Top insiders

Download results Settings

Jull, Gage Philip

Director of Issuer

2 purchases — total 6,232 CAD

Buy 19 Oct 2022

Value CA$3,250,835.06 | Price 86.37 | Shares 64,301

Buy 19 Oct 2022

Value CA$715,557.20 | Price 348.47 | Shares 84,570

Jull, Gage Philip

Director of Issuer

1 purchase — total 5,161 CAD

Buy 11 Oct 2022

Value CA$4,946,027.66 | Price 497.94 | Shares 65,668

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2022-10-25	2022-10-19	B Purchase	1.5 Jull, Gage Philip Director of Issuer Non-Executive Director	64,301 -3.4% 86.37 CA$3,250,835	64,301 -3.4%	86.37	CA$3,250,835
2022-10-25	2022-10-19	B Purchase	1.5 Jull, Gage Philip Director of Issuer Non-Executive Director	84,570 -25.1% 348.47 CA$715,557	84,570 -25.1%	348.47	CA$715,557
2022-10-25	2022-10-11	B Purchase	1.5 Jull, Gage Philip Director of Issuer Non-Executive Director	65,668 -48.1% 497.94 CA$4,946,028	65,668 -48.1%	497.94	CA$4,946,028

More insider trading research around Tryp Therapeutics Inc.